| 1 |
Expression and function of periostin‐isoforms in bone
Judith Litvin, Abdulhafez Selim, Michael O. Montgomery et al. · Journal of Cellular Biochemistry
|
14 Jun 2004 |
182 |
| 2 |
Mixed Messages
Kenneth B. Margulies, Sunil Matiwala, Carla Cornejo et al. · Circulation Research
Open access |
18 Feb 2005 |
179 |
| 3 |
Structural studies of Chikungunya virus maturation
Moh Lan Yap, Thomas Klose, Akane Urakami et al. · Proceedings of the National Academy of Sciences
Open access |
4 Dec 2017 |
156 |
| 4 |
Safety and immunogenicity of PXVX0317, an aluminium hydroxide-adjuvanted chikungunya virus-like particle vaccine: a randomised, double-blind, parallel-group, phase 2 trial
Sean Bennett, James M McCarty, Roshan Ramanathan et al. · The Lancet Infectious Diseases
|
13 Jun 2022 |
81 |
| 5 |
An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design
Akane Urakami, Mya Myat Ngwe Tun, Meng Ling Moi et al. · Journal of Virology
Open access |
27 Sep 2017 |
78 |
| 6 |
Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity
Feng Long, Rachel H. Fong, S. Kyle Austin et al. · Proceedings of the National Academy of Sciences
Open access |
26 Oct 2015 |
60 |
| 7 |
Clinical trials of self-replicating RNA-based cancer vaccines
Michael Andrew Morse, Erika J. Crosby, Jeremy Meyer Force et al. · Cancer Gene Therapy
Open access |
10 Feb 2023 |
57 |
| 8 |
Long-term survival of patients with stage III colon cancer treated with VRP-CEA(6D), an alphavirus vector that increases the CD8+ effector memory T cell to Treg ratio
Erika J. Crosby, Amy C. Hobeika, Donna Niedzwiecki et al. · Journal for ImmunoTherapy of Cancer
Open access |
Nov 2020 |
54 |
| 9 |
Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
Akane Urakami, Atsuko Sakurai, Momoko Ishikawa et al. · Clinical and Vaccine Immunology
Open access |
18 May 2017 |
50 |
| 10 |
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing an anchored RBD: A randomized, observer-blind phase 1 study
Wataru Akahata et al. · Cell Reports Medicine
Open access |
Aug 2023 |
43 |
| 11 |
saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
Mai Komori, Takuto Nogimori, Amber L. Morey et al. · Nature Communications
Open access |
19 May 2023 |
39 |
| 12 |
Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine
Masayuki Aboshi, Kenta Matsuda, Daisuke Kawakami et al. · iScience
Open access |
22 Jan 2024 |
37 |
| 13 |
Reassessing therapeutic antibodies for neglected and tropical diseases
Rob Hooft van Huijsduijnen, Somei Kojima, Dee A. Carter et al. · PLoS neglected tropical diseases
Open access |
30 Jan 2020 |
34 |
| 14 |
Structural Studies of Chikungunya Virus-Like Particles Complexed with Human Antibodies: Neutralization and Cell-to-Cell Transmission
Jason C. Porta, Vidya Mangala Prasad, Cheng‐I Wang et al. · Journal of Virology
Open access |
4 Nov 2015 |
33 |
| 15 |
A tetravalent dengue virus-like particle vaccine induces high levels of neutralizing antibodies and reduces dengue replication in non-human primates
Daniel Thoresen, Kenta Matsuda, Akane Urakami et al. · Journal of Virology
Open access |
22 Apr 2024 |
31 |
| 16 |
Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine
Mai Komori, Amber L. Morey, Andrés A. Quiñones-Molina et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
Nov 2023 |
23 |
| 17 |
Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle array patch delivery
Madison M. Driskill, Ian A. Coates, Paul Joshua Hurst et al. · Journal of Controlled Release
Open access |
9 Jun 2025 |
17 |
| 18 |
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines
Denny Kim, James S. Robertson, Jean‐Louis Excler et al. · Vaccine
Open access |
19 Jun 2020 |
17 |
| 19 |
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines
RICHARD C. CONDIT, Denny Kim, James S. Robertson et al. · Vaccine
Open access |
6 Sep 2020 |
9 |
| 20 |
Incorporation of 5-methylcytidine alleviates RIG-I–mediated innate immune responses to a self-amplifying RNA vaccine
Wataru Akahata, Mai Komori, Amber L. Morey et al. · Science Translational Medicine
Open access |
12 Nov 2025 |
8 |
| 21 |
Pharmacological Effects of ATI22-107 [2-(2-{2-[2-Chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylic Acid Dimethyl Ester)], a Novel Dual Pharmacophore, on Myocyte Calcium Cycling and Contractility
Albert S. Jung, Michael P. Quaile, Geoffrey D. Mills et al. · Journal of Pharmacology and Experimental Therapeutics
|
15 Jan 2005 |
4 |
| 22 |
Safety, immunogenicity, and optimal dosing of VLPCOV-02, a SARS-CoV-2 saRNA vaccine with modified 5-methylcytosine base
Masayuki Aboshi, Daisuke Kawakami, Kaoru Kono et al. · iScience
Open access |
22 Jan 2026 |
2 |
| 23 |
Safety and immunogenicity of VLPCOV-02, a SARS-CoV-2 self-amplifying RNA vaccine with a modified base, 5-methylcytosine, in healthy individuals
Masayuki Aboshi, Kenta Matsuda, Daisuke Kawakami et al. · medRxiv
PreprintOpen access |
6 Sep 2023 |
2 |
| 24 |
A global map of the Zika virus phosphoproteome reveals host-driven regulation of viral budding and cytopathogenicity
Inessa Manuelyan, Anna M. Schmoker, Boyd L. Yount et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
25 Nov 2021 |
2 |
| 25 |
Cholesterol-containing ionizable lipids for safe and efficient mRNA delivery via lipid nanoparticles
Liang Xie, Haiyang Li, Jiangsheng Xu et al. · New Journal of Chemistry
|
2026 |
1 |
| 26 |
Coordinated Temporal Dynamics of Glucocorticoid Receptor Binding and Chromatin Landscape Drive Transcriptional Regulation
Diana A. Stavreva, Sohyoung Kim, Saori Fujiwara et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
25 Apr 2026 |
1 |
| 27 |
Safety and immunogenicity of SARS-CoV-2 self-amplifying RNA vaccine expressing anchored RBD: a randomised, observer-blind, phase 1 study
Wataru Akahata et al. · medRxiv
PreprintOpen access |
22 Nov 2022 |
1 |
| 28 |
ClC-2 Chloride Channels
John Cuppoletti, Danuta H. Malinowska, Ryuji Ueno · Physiology in health and disease
Book chapter |
2020 |
1 |
| 29 |
Identification of myocardial recovery genes with a multi-comparison PRISM
Kenneth B. Margulies, Tara Eskandari, Sunil Matiwala et al. · Journal of Cardiac Failure
|
12 Sep 2003 |
1 |
| 30 |
P4‐291: Identification and validation of a blood‐based transcriptomic signature (AclarusDx) in the diagnosis of Alzheimer's disease
Rich Einstein, Olivier Sol, Pascale Beurdeley et al. · Alzheimer s & Dementia
|
Jul 2011 |
1 |
| 31 |
A global map of the Zika virus phosphoproteome reveals host-driven regulation of viral particle release and cytopathogenicity
Inessa Manuelyan, Anna M. Schmoker, Boyd L. Yount et al. · PLoS Pathogens
Open access |
3 Sep 2026 |
0 |
| 32 |
Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV Prevention
M. Melissa Peet, Vivek Agrahari, Parbeen Singh et al. · Molecular Pharmaceutics
Open access |
14 Jul 2026 |
0 |
| 33 |
Spatial Tail Design in Ionizable Lipids Enhances the Safety and Efficacy of mRNA Delivery
Hui Li, Chongyu Tian, Weining Kong et al. · Small Methods
Open access |
26 Jun 2026 |
0 |
| 34 |
A chikungunya virus-like particle vaccine reduces chikungunya disease in cynomolgus macaques and protection is mediated by antibody transferred from vaccinated humans
Lark L. Coffey et al. · npj Vaccines
Open access |
18 Mar 2026 |
0 |
| 35 |
Alphavirus replicon particle expressing IL-12 reprograms tumor-associated macrophages and neutrophils and induces anti-tumor immunity
Momoko Ishikawa, Dhanya K. Nambiar, Jaya Sastri et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
11 Aug 2025 |
0 |
| 36 |
Antigen Dose and Persistence Contribute to Induction of a Durable HIV-1-Specific Neutralizing Antibody Response
Mark Connors et al. · Research Square
PreprintOpen access |
23 Dec 2024 |
0 |
| 37 |
A Tetravalent Dengue Virus-like Particle Vaccine Induces High levels of Neutralizing Antibodies and Inhibits Dengue Replication in Non-Human Primates
Daniel Thoresen, Kenta Matsuda, Akane Urakami et al. · bioRxiv (Cold Spring Harbor Laboratory)
PreprintOpen access |
16 Oct 2023 |
0 |
| 38 |
P4‐290: Blood transcriptomic signatures of Alzheimer's patients treated with a novel Alzheimer's disease drug, EHT 0202, allow identification of novel potential biomarkers correlated with treatment response and efficacy
Laurent Désiré, Jennyfer Carriere, Elodie Blondiaux et al. · Alzheimer s & Dementia
|
Jul 2011 |
0 |